<DOC>
	<DOCNO>NCT00982267</DOCNO>
	<brief_summary>The purpose study define Maximum tolerate dose SU14813 administer single agent patient solid tumor .</brief_summary>
	<brief_title>A Trial Of SU14813 In Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description />
	<criteria>Patients histologically proven advanced solid malignancy recognize therapy available standard therapy fail Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Serum albumin â‰¥3.0 g/dL adequate haemopoietic , renal liver function Chemotherapy within 3 week ( 6 week nitrosoureas mitomycin C ) radiotherapy investigational agent within 4 week start study treatment Subjects recover prior treatment toxicity , except alopecia , major surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>cancer</keyword>
</DOC>